home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Study Shows Connection Between 3 Proteins Involved in Cancer

 
  October, 6 2000 2:11
your information resource in human molecular genetics
 
     
A TALE OF THREE PROTEINS

In mammalian cells, ‘Id’ proteins help control cell proliferation and differentiation, which can be important in tumour progression. Another protein, ‘Rb’, also helps restrict cell proliferation. The gene coding Rb is one of the most important tumour suppressor genes studied and normal Rb function is removed in just about all human tumours. A third protein, ‘Myc’, is a transcription factor also strongly implicated in driving cell proliferation — Myc activity runs amok in many cancers and can force cells to bypass the inhibitory Rb pathway.

This week (Nature, 05 Oct 2000, VOL. 407, NO. 6804), Antonio Iavarone and colleagues at the Albert Einstein College of Medicine, New York, report intriguing further connections between the three proteins. By investigating mice that cannot express ‘Id2’ or Rb, they found that, during the normal cell cycle, Rb stops Id acting on its usual targets. But when Myc is overexpressed, it subverts the Rb’s tumour suppression activity by directly activating the Id2 gene. This may have a key role in a very aggressive neuronal cancer called neuroblastoma.

The work, therefore, connects three proteins known to be involved in cancer, and helps show how they act together to derail the cell cycle, producing uncontrolled cell proliferation. Inhibiting Id2-protein activity in tumour cells that overexpress Myc could help restore Rb proliferation control, the researchers say.

CONTACT

Antonio Iavarone
tel +1 718 430 3347
fax +1 718 430 8785
email iavarone@aecom.yu.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.